{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:10:08Z","timestamp":1787062208953,"version":"build-2736575974"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144263","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T16:54:48Z","timestamp":1449593688000},"page":"e0144263","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions"],"prefix":"10.1371","volume":"10","author":[{"given":"Masayuki","family":"Hashiguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"SJ Evans","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/ijms.6048","article-title":"Data mining of the public version of the FDA Adverse Event Reporting System","volume":"10","author":"T Sakaeda","year":"2013","journal-title":"Int J Med Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/amiajnl-2011-000214","article-title":"A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports","volume":"19","author":"NP Tatonetti","year":"2012","journal-title":"J Am Med Inform Assoc"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"i611","DOI":"10.1093\/bioinformatics\/bts413","article-title":"Drug target prediction using adverse event report systems: a pharmacogenomic approach","volume":"28","author":"M Takarabe","year":"2012","journal-title":"Bioinformatics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"EP van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System","volume":"53","author":"W DuMouchel","year":"1999","journal-title":"Am Stat"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"DuMouchel W, Pregibon D. Empirical Bayes screening for multi-item associations. In: Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, Provost F, Srikant R, ACM New York, Ny, USA, 2001 67\u201376.","DOI":"10.1145\/502512.502526"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"A Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1002\/sim.2473","article-title":"Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events","volume":"25","author":"GN Nor\u00e9n","year":"2006","journal-title":"Stat Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s40264-014-0225-0","article-title":"Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS)","volume":"37","author":"KB Hoffman","year":"2014","journal-title":"Drug Saf"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"A Bate","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pds.771","article-title":"Practical pharmacovigilance analysis strategies","volume":"12","author":"AL Gould","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.clpt.6100258","article-title":"Novel statistical tools for monitoring the safety of marketed drugs","volume":"82","author":"JS Almenoff","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref14","unstructured":"21CFR Part 312.32 General Instructions-IND safety reports. What type of safety information must I report to the FDA, Available: https:\/\/www.dtmi.duke.edu\/sites\/default\/files\/documents\/regulatory_templates\/6.-IND-Safety-Letter-Instruction-Sheet.pdf<\/ext-link><\/underline>. Accessed 1 January 2012."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/00002018-200528110-00002","article-title":"Perspectives on the use of data mining in pharmacovigilance","volume":"28","author":"J Almenoff","year":"2005","journal-title":"Drug Saf"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00002018-200225060-00002","article-title":"A data mining approach for signal detection and analysis","volume":"25","author":"A Bate","year":"2002","journal-title":"Drug Saf"},{"key":"ref17","article-title":"Public Health Advisory: Ketek (telithromycin) Tables","year":"2006"},{"key":"ref18","article-title":"Early Communication About an Ongoing Safety Review of Varenicline (marketed as Chantix)","year":"2007"},{"key":"ref19","unstructured":"Public Health Advisory: Important Information on Chantix (varenicline), February 1, 2008, U.S. Food and Administration Available: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/PublicHealthAdvisories\/ucm051136.htm<\/ext-link><\/underline>. Accessed 1 January 2012."},{"key":"ref20","unstructured":"Information for Healthcare Professionals: Exenatide (marketed as Byetta), October 2007, U.S. Food and Administration Available: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124712.htm<\/ext-link><\/underline>. Accessed 1 January 2012."},{"key":"ref21","unstructured":"Information for Healthcare Professionals: Exenatide (marketed as Byetta), August 2008, Update U.S. Food and Administration, Available: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124713.htm<\/ext-link><\/underline>. Accessed 1 January 2012."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15200","article-title":"Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys","volume":"15","author":"AJ Avery","year":"2011","journal-title":"Health Technol Assess"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/pds.1275","article-title":"Reports of hyperkalemia after publication of RALES\u2014a pharmacovigilance study","volume":"15","author":"M Hauben","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref24","first-page":"59","article-title":"Utilization of the spontaneous report data to the signal detection","volume":"54","author":"K Kubota","year":"2003","journal-title":"J Pract Pharm"},{"key":"ref25","unstructured":"Pharmaceuticals and Medical Devices Agency. Report about introduction of data-mining technique. March 2007. (In Japanese)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3820\/jjpe.16.27","article-title":"Database and record linkage in Asia","volume":"16","author":"K Kubota","year":"2011","journal-title":"Jpn J Pharmacoepidemiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T18:17:02Z","timestamp":1718216222000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144263"}},"subtitle":[],"editor":[{"given":"Yoshihiro","family":"Yamanishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144263","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]}}}